Literature DB >> 7066899

Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines.

P B Armstrong, J P Quigley, E Sidebottom.   

Abstract

The ability of cultured tumor cell lines to invade across epithelia was studied by placing 10(4) to 10(6) dispersed cells on the chorionic epithelium (CE) of the chorioallantoic membrane of the 10-day chick embryo. Tumor lines included Walker carcinosarcoma, F87 cl 6T2 and B16-BL6 melanomas, and KiSV-NIH, 3B77SC4, and HT 1080 sarcomas. The CE is a bilayer of cells with a superficial periderm overlying a basal layer. Invasion across an intact CE was very weak (limited to the formation of "microtumors" by a small fraction of the inoculated cells in 5 to 50% of the embryos) but was massive (most or all of the inoculated cells invaded in over 99% of the embryos) if the chorioallantoic membrane was traumatized in a fashion which disrupted the periderm but left the basal layer intact. Normal fibroblasts also invaded across the traumatized CE. The histological picture of invasion suggests that cells inoculated on the traumatized CE induced large-scale active retraction of the basal layer, resulting in the formation of large gaps in its continuity. Migration into the subjacent mesoderm occurred through these gaps. The nodules formed by both tumorigenic and normal cells became extensively vascularized within 3 days.

Entities:  

Mesh:

Year:  1982        PMID: 7066899

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Induction of c-met proto-oncogene expression at the metastatic site.

Authors:  J Imai; M Watanabe; M Sasaki; R Yamaguchi; S Tateyama; S Sugano
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Assay systems for screening food components that have anti-proliferative and anti-invasive activity to rat ascites hepatoma cells: In vitro and ex vivo effects of green tea extract.

Authors:  Y Miura; H Shiomi; F Sakai; K Yagasaki
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

Review 3.  Fibroblasts and the ground they walk on.

Authors:  Daniel J Tschumperlin
Journal:  Physiology (Bethesda)       Date:  2013-11

4.  Inhibitory effects of Semaphorin 3F as an alternative candidate to anti-VEGF monoclonal antibody on angiogenesis.

Authors:  Gamze Tan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-16       Impact factor: 2.416

5.  Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well.

Authors:  S Koop; E E Schmidt; I C MacDonald; V L Morris; R Khokha; M Grattan; J Leone; A F Chambers; A C Groom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Investigations into the potential role of aberrant N-acetylgalactosamine glycans in tumour cell interactions with basement membrane components.

Authors:  Susan A Brooks; Debbie M S Hall
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Effect of IL-6 on tumor cell invasion of vascular endothelial monolayers.

Authors:  Y Kitamura; I Morita; Z Nihei; Y Mishima; S Murota
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

8.  An autologous system for culturing head and neck squamous cell carcinomas for the assessment of cellular therapies on the chorioallantois membrane.

Authors:  S Gronau; B Thess; H Riechelmann; Y Fischer; A Schmitt; M Schmitt
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-27       Impact factor: 2.503

Review 9.  Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.

Authors:  J S Rao; P A Steck; P Tofilon; D Boyd; F Ali-Osman; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 10.  Invasion in vitro. Methods of analysis.

Authors:  M M Mareel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.